Sickle cell disease: A multigenic perspective of a single gene disorder

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The phenotypic heterogeneity of sickle cell disease continues to puzzle clinicians and investigators more than half a century after the elucidation of its molecular basis. Although advances have been made in understanding the influences of globin gene-related factors such as α-thalassemia (thal) and high Hb F determinants, these are far from providing a satisfactory explanation to the variation and clinical diversity of sickle cell disease in many cases. The sequencing of the human genome and the development of novel technologies such as high throughput genotyping and analysis of gene expression through cDNA microarrays has made it possible to investigate this diversity with these approaches and identify novel genetic modifiers of sickle cell disease. This brief review focuses on the recent advances in our understanding of the impact of non globin genetic modifiers on the phenotypic diversity of the disease.

Original languageEnglish (US)
Pages (from-to)209-224
Number of pages16
JournalHemoglobin
Volume31
Issue number2
DOIs
StatePublished - Apr 1 2007

Fingerprint

Sickle Cell Anemia
Globins
Genes
Thalassemia
Human Development
Human Genome
Oligonucleotide Array Sequence Analysis
Microarrays
Research Personnel
Gene expression
Technology
Gene Expression
Complementary DNA
Throughput

Keywords

  • Genetic modifiers
  • Phenotypic diversity
  • Sickle cell disease

ASJC Scopus subject areas

  • Hematology
  • Clinical Biochemistry
  • Genetics(clinical)
  • Biochemistry, medical

Cite this

Sickle cell disease : A multigenic perspective of a single gene disorder. / Kutlar, Abdullah.

In: Hemoglobin, Vol. 31, No. 2, 01.04.2007, p. 209-224.

Research output: Contribution to journalArticle

@article{bd74abe3fbd74dd3a15a18c4f47a2127,
title = "Sickle cell disease: A multigenic perspective of a single gene disorder",
abstract = "The phenotypic heterogeneity of sickle cell disease continues to puzzle clinicians and investigators more than half a century after the elucidation of its molecular basis. Although advances have been made in understanding the influences of globin gene-related factors such as α-thalassemia (thal) and high Hb F determinants, these are far from providing a satisfactory explanation to the variation and clinical diversity of sickle cell disease in many cases. The sequencing of the human genome and the development of novel technologies such as high throughput genotyping and analysis of gene expression through cDNA microarrays has made it possible to investigate this diversity with these approaches and identify novel genetic modifiers of sickle cell disease. This brief review focuses on the recent advances in our understanding of the impact of non globin genetic modifiers on the phenotypic diversity of the disease.",
keywords = "Genetic modifiers, Phenotypic diversity, Sickle cell disease",
author = "Abdullah Kutlar",
year = "2007",
month = "4",
day = "1",
doi = "10.1080/03630260701290233",
language = "English (US)",
volume = "31",
pages = "209--224",
journal = "Hemoglobin",
issn = "0363-0269",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Sickle cell disease

T2 - A multigenic perspective of a single gene disorder

AU - Kutlar, Abdullah

PY - 2007/4/1

Y1 - 2007/4/1

N2 - The phenotypic heterogeneity of sickle cell disease continues to puzzle clinicians and investigators more than half a century after the elucidation of its molecular basis. Although advances have been made in understanding the influences of globin gene-related factors such as α-thalassemia (thal) and high Hb F determinants, these are far from providing a satisfactory explanation to the variation and clinical diversity of sickle cell disease in many cases. The sequencing of the human genome and the development of novel technologies such as high throughput genotyping and analysis of gene expression through cDNA microarrays has made it possible to investigate this diversity with these approaches and identify novel genetic modifiers of sickle cell disease. This brief review focuses on the recent advances in our understanding of the impact of non globin genetic modifiers on the phenotypic diversity of the disease.

AB - The phenotypic heterogeneity of sickle cell disease continues to puzzle clinicians and investigators more than half a century after the elucidation of its molecular basis. Although advances have been made in understanding the influences of globin gene-related factors such as α-thalassemia (thal) and high Hb F determinants, these are far from providing a satisfactory explanation to the variation and clinical diversity of sickle cell disease in many cases. The sequencing of the human genome and the development of novel technologies such as high throughput genotyping and analysis of gene expression through cDNA microarrays has made it possible to investigate this diversity with these approaches and identify novel genetic modifiers of sickle cell disease. This brief review focuses on the recent advances in our understanding of the impact of non globin genetic modifiers on the phenotypic diversity of the disease.

KW - Genetic modifiers

KW - Phenotypic diversity

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=34248208603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248208603&partnerID=8YFLogxK

U2 - 10.1080/03630260701290233

DO - 10.1080/03630260701290233

M3 - Article

C2 - 17486504

AN - SCOPUS:34248208603

VL - 31

SP - 209

EP - 224

JO - Hemoglobin

JF - Hemoglobin

SN - 0363-0269

IS - 2

ER -